Polatuzumab vedotin Interactions
There are 408 drugs known to interact with polatuzumab vedotin, along with 5 disease interactions. Of the total drug interactions, 79 are major, 316 are moderate, and 13 are minor.
- View all 408 medications that may interact with polatuzumab vedotin
- View polatuzumab vedotin disease interactions (5)
Most frequently checked interactions
View interaction reports for polatuzumab vedotin and the medicines listed below.
- Aloprim (allopurinol)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Colace (docusate)
- Curcumin 95 (turmeric)
- Ginger Root (ginger)
- Lexapro (escitalopram)
- Linzess (linaclotide)
- Pepcid (famotidine)
- Pepcid AC (famotidine)
- Pradaxa (dabigatran)
- Senna S (docusate/senna)
- Septra DS (sulfamethoxazole / trimethoprim)
- Xarelto (rivaroxaban)
Polatuzumab vedotin disease interactions
There are 5 disease interactions with polatuzumab vedotin which include:
More about polatuzumab vedotin
- polatuzumab vedotin consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Monjuvi
Monjuvi (tafasitamab-cxix) is used for the treatment of relapsed or refractory diffuse large B-cell ...
Kymriah
Kymriah is used to treat acute lymphoblastic leukemia (ALL) that is relapsing or refractory in ...
Yescarta
Yescarta is used to treat large B-cell lymphoma and follicular lymphoma, two types of non-Hodgkin ...
Breyanzi
Breyanzi is a CAR T cell therapy for large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle ...
Polivy
Polivy (polatuzumab vedotin-piiq) is a targeted treatment that may be used to treat diffuse large ...
Xpovio
Xpovio is used to treat multiple myeloma (MM) or relapsed/refractory diffuse large B-cell lymphoma ...
Lunsumio
Lunsumio (mosunetuzumab-axgb) is used for the treatment of relapsed or refractory follicular ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.